Evidence map›Paper›PMID 34888844›Full record

ArticleAdvances in experimental medicine and biology2021

Exosomes in the Healthy and Malignant Bone Marrow Microenvironment.

Caitlyn A Moore, Alejandra I Ferrer, Sara Alonso, Sri Harika Pamarthi, Oleta A Sandiford, Pranela Rameshwar

Abstract read
PubMed Publisher
In one paragraph

Article in Advances in experimental medicine and biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Caitlyn A MooreRutgers New Jersey Medical School, Rutgers University, Newark, NJ, United States.
Alejandra I FerrerRutgers New Jersey Medical School, Rutgers University, Newark, NJ, United States.
Sara AlonsoRutgers School of Graduate Studies at New Jersey Medical School, Rutgers University, Newark, NJ, United States.
Sri Harika PamarthiRutgers New Jersey Medical School, Rutgers University, Newark, NJ, United States.
Oleta A SandifordRutgers New Jersey Medical School, Rutgers University, Newark, NJ, United States.
Pranela RameshwarRutgers New Jersey Medical School, Rutgers University, Newark, NJ, United States. rameshwa@njms.rutgers.edu.
Rutgers, The State University of New Jersey · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The bone marrow (BM) is a complex organ that sustains hematopoiesis via mechanisms involving the microenvironment. The microenvironment includes several cell types, neurotransmitters from innervated fibers, growth factors, extracellular matrix proteins, and extracellular vesicles. The main function of the BM is to regulate hematopoietic function to sustain the production of blood and immune cells. However, the BM microenvironment can also accommodate the survival of malignant cells. A major mechanism by which the cancer cells communicate with cells of the BM microenvironment is through the exchange of exosomes, a subset of extracellular vesicles that deliver molecular signals bidirectionally between malignant and healthy cells. The field of exosomes is an active area of investigation since an understanding of how the exosomal packaging, cargo, and production can be leveraged therapeutically to deter cancer progression and sensitize malignant cells to other therapies. Altogether, this chapter discusses the crucial role of exosomes in the development and progression of BM-associated cancers, such as hematologic malignancies and marrow-metastatic breast cancer. Exosome-based therapeutic strategies and their limitations are also considered.

Indexed as

ExosomesExtracellular VesiclesBone MarrowCell CommunicationTumor MicroenvironmentBone marrowCancerExosomesMicroenvironmentTherapeutics

Identifiers

PMID34888844
OpenAlexW4206363282

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.